Hocoma AG has merged with DIH International
Hocoma AG, a global leader in robotic and sensor-based rehabilitation solutions, has merged with DIH International (DIH), a Hong Kong-based corporate holding group with offices in China, Korea, the Netherlands and the USA. Financial details have not been disclosed.
Hocoma was founded in 1996 by two electrical and biomedical engineers, Gery Colombo and Matthias Jörg, and by the economist Peter Hostettler. The Swiss-based medical technology company works closely with leading clinics and research centers to develop innovative therapies. The company currently has over 160 employees, who work at its headquarters near Zurich and subsidiaries in the US, Singapore and Slovenia.
DIH focuses on rehabilitation solutions and medication management. Its robotic and sensor-based devices are used in applications ranging from intensive gait therapy and functional therapy for the upper extremities to robotic mobilization and functional electrical stimulation in early rehabilitation. Prior to the Hocoma merger, DIH acquired two Dutch companies, Motekforce Link, a leader in virtual rehabilitation, and FysioRoadmap MRS, which specializes in web-based clinical programs and data integration. All told, DIH has nearly a thousand employees in locations including Amsterdam, Seoul and Beijing.
With regard to the merger, “For Hocoma, this is the next big step into the future,” says Gery Colombo, the company’s CEO. “Due to an aging society, the rehabilitation market is one of the biggest growth markets in the health industry. Now, we can offer clinicians the best solutions for their patients—as a holistic, full service provider of the entire rehabilitation continuum.”
"The combination – adds Jason Chen, CEO of DIH – enables us to establish a global premiership in providing total solutions to customers with cutting edge technologies in robotics, VR, sensing and automation.”
Oaklins’ team in Switzerland advised Hocoma’s owners before and during the sales process, the negotiations with selected parties and the eventual merger with DIH.
Talk to the deal team
Related deals
Rare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreLauak Group has sold a majority stake to Wipro Infrastructure Engineering
After careful strategic reflection to secure the group’s future, Lauak Group’s shareholders have chosen an industrial partnership, in line with the ongoing consolidation trend in the market. Attracted by opportunities for innovation and international expansion, the Charritton family, founders and long-term shareholders, regard Wipro Infrastructure Engineering as a trusted industrial partner. The historical shareholders remain minority stakeholders, and the current CEO continues to lead Lauak.
Learn more